Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

NCT01979380 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Toxicity

Interventions

DRUG: KD101
DRUG: placebo

Sponsor

Kwang Dong Pharmaceutical co., ltd.